Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 15 studies | 83% ± 15% | |
glutamatergic neuron | 12 studies | 68% ± 20% | |
GABAergic neuron | 11 studies | 50% ± 21% | |
astrocyte | 6 studies | 34% ± 16% | |
fibroblast | 6 studies | 20% ± 2% | |
neuron | 6 studies | 47% ± 20% | |
endothelial cell | 6 studies | 35% ± 21% | |
interneuron | 6 studies | 58% ± 10% | |
endothelial cell of lymphatic vessel | 5 studies | 26% ± 4% | |
granule cell | 4 studies | 46% ± 9% | |
connective tissue cell | 3 studies | 42% ± 19% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 75% ± 6% | |
GABAergic interneuron | 3 studies | 56% ± 13% | |
progenitor cell | 3 studies | 46% ± 20% | |
glycinergic amacrine cell | 3 studies | 34% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 41% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1030.31 | 2632 / 2642 | 99% | 28.18 | 696 / 705 |
breast | 88% | 444.80 | 406 / 459 | 62% | 4.96 | 695 / 1118 |
thymus | 64% | 168.78 | 416 / 653 | 63% | 4.97 | 379 / 605 |
skin | 57% | 274.85 | 1036 / 1809 | 61% | 14.01 | 289 / 472 |
uterus | 95% | 462.06 | 161 / 170 | 19% | 2.04 | 85 / 459 |
bladder | 100% | 417.71 | 21 / 21 | 7% | 0.33 | 34 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.95 | 1 / 1 |
blood vessel | 99% | 1097.41 | 1324 / 1335 | 0% | 0 | 0 / 0 |
ovary | 92% | 428.11 | 166 / 180 | 4% | 0.17 | 17 / 430 |
prostate | 83% | 332.58 | 204 / 245 | 7% | 0.18 | 33 / 502 |
esophagus | 66% | 276.50 | 959 / 1445 | 20% | 0.78 | 36 / 183 |
intestine | 73% | 342.07 | 707 / 966 | 7% | 0.36 | 35 / 527 |
adipose | 78% | 247.59 | 934 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 17% | 35.45 | 43 / 258 | 54% | 3.64 | 124 / 230 |
heart | 67% | 229.70 | 578 / 861 | 0% | 0 | 0 / 0 |
stomach | 38% | 166.65 | 136 / 359 | 12% | 0.48 | 33 / 286 |
pancreas | 7% | 10.89 | 22 / 328 | 38% | 1.33 | 67 / 178 |
spleen | 34% | 82.99 | 83 / 241 | 0% | 0 | 0 / 0 |
lung | 24% | 56.44 | 137 / 578 | 9% | 0.41 | 99 / 1155 |
kidney | 3% | 6.53 | 3 / 89 | 17% | 0.88 | 157 / 901 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.40 | 5 / 45 |
eye | 0% | 0 | 0 / 0 | 4% | 0.08 | 3 / 80 |
liver | 1% | 1.71 | 3 / 226 | 2% | 0.05 | 8 / 406 |
muscle | 2% | 3.93 | 17 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.15 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048701 | Biological process | embryonic cranial skeleton morphogenesis |
GO_0001501 | Biological process | skeletal system development |
GO_0097094 | Biological process | craniofacial suture morphogenesis |
GO_0016485 | Biological process | protein processing |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0035988 | Biological process | chondrocyte proliferation |
GO_0030574 | Biological process | collagen catabolic process |
GO_0001958 | Biological process | endochondral ossification |
GO_0006508 | Biological process | proteolysis |
GO_0005615 | Cellular component | extracellular space |
GO_0005796 | Cellular component | Golgi lumen |
GO_0009986 | Cellular component | cell surface |
GO_0005886 | Cellular component | plasma membrane |
GO_0031012 | Cellular component | extracellular matrix |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0008047 | Molecular function | enzyme activator activity |
GO_0070006 | Molecular function | metalloaminopeptidase activity |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | MMP16 |
Protein name | Matrix metallopeptidase 16 Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP) |
Synonyms | MMPX2 C8orf57 |
Description | FUNCTION: Endopeptidase that degrades various components of the extracellular matrix, such as collagen type III and fibronectin. Activates progelatinase A. Involved in the matrix remodeling of blood vessels. Isoform short cleaves fibronectin and also collagen type III, but at lower rate. It has no effect on type I, II, IV and V collagen. However, upon interaction with CSPG4, it may be involved in degradation and invasion of type I collagen by melanoma cells. . |
Accessions | ENST00000522726.1 P51512 ENST00000286614.11 [P51512-1] E5RJA7 |